Kallmann Syndrome
What is Kallmann syndrome?
Kallmann syndrome is a rare genetic condition that affects sexual development and the sense of smell. People with this condition experience delayed puberty or puberty that never starts on its own. This happens because the body does not produce enough of the hormones needed for sexual development.
The hallmark feature is the combination of low sex hormones and an impaired or absent sense of smell, called anosmia. The brain does not properly signal the release of hormones like luteinizing hormone, or LH, and follicle-stimulating hormone, or FSH. These hormones tell the body to start puberty and maintain reproductive function.
Kallmann syndrome affects roughly 1 in 30,000 males and 1 in 120,000 females. It is a lifelong condition, but with proper hormone therapy, most people can develop secondary sexual characteristics and lead healthy lives. Early diagnosis and treatment help prevent complications and support normal development.
Symptoms
- Delayed or absent puberty, no development of secondary sexual characteristics by age 13 in girls or 14 in boys
- Reduced or absent sense of smell, often present from birth but not always noticed
- Small testes in males
- Lack of menstrual periods in females
- Low sex drive or absent libido
- Infertility or difficulty conceiving
- Micropenis or undescended testes in infant males
- Reduced facial and body hair
- Poor bone density over time if untreated
Some people may not realize they have a reduced sense of smell until specifically tested. Symptoms become most apparent during the teenage years when puberty should normally begin.
Concerned about Kallmann syndrome? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Kallmann syndrome is caused by genetic mutations that disrupt the development of nerve cells that control hormone production. These nerve cells are responsible for releasing gonadotropin-releasing hormone, or GnRH. Without proper GnRH signaling, the pituitary gland does not release enough LH and FSH to trigger puberty.
The condition can be inherited in several ways, including X-linked, autosomal dominant, or autosomal recessive patterns. Many different genes can cause Kallmann syndrome, with mutations in the KAL1 gene being one of the most common. However, some cases occur spontaneously with no family history. Males are more often affected than females, and severity can vary widely even within the same family.
How it's diagnosed
Diagnosis involves a combination of clinical evaluation, smell testing, hormone blood tests, and imaging studies. A doctor will assess whether puberty has progressed normally and test the sense of smell using standardized smell identification tests. Blood tests measuring LH, FSH, testosterone in males, or estrogen in females help confirm low hormone levels.
A GnRH stimulation test may be performed to see how the pituitary gland responds to hormone signals. MRI imaging of the brain can reveal abnormalities in the olfactory bulbs, the structures responsible for smell. Genetic testing may identify specific mutations but is not always necessary for diagnosis. Talk to a doctor about specialized hormone testing and evaluation if you or your child show signs of delayed puberty combined with smell issues.
Treatment options
- Hormone replacement therapy with testosterone for males to develop secondary sexual characteristics and maintain bone health
- Estrogen and progesterone therapy for females to trigger breast development, menstruation, and protect bones
- Gonadotropin injections containing LH and FSH to stimulate the testes or ovaries when fertility is desired
- Pulsatile GnRH therapy delivered through a pump to mimic natural hormone patterns
- Calcium and vitamin D supplements to support bone density
- Regular monitoring of hormone levels and bone health with blood tests and bone density scans
- Psychological support and counseling to address emotional impacts of delayed development
- Fertility treatments when planning to conceive
Frequently asked questions
The main sign is delayed or absent puberty combined with a reduced or absent sense of smell. In teenagers, this means no development of secondary sexual characteristics like breast development in girls or testicular enlargement in boys by the expected age. The smell impairment is often present from birth but may go unnoticed until specifically tested.
Yes, in some male infants, signs like micropenis or undescended testes may suggest the condition early on. However, most cases are not diagnosed until the teenage years when puberty fails to start. Early diagnosis allows for timely treatment planning and better outcomes.
No, Kallmann syndrome is a specific cause of delayed puberty with the added feature of impaired smell. Many teens have constitutional delay of puberty, which is temporary and resolves on its own. Kallmann syndrome requires lifelong hormone therapy and does not resolve without treatment.
Blood tests measure levels of sex hormones and pituitary hormones like LH and FSH. In Kallmann syndrome, these hormones are typically very low. A GnRH stimulation test can show whether the pituitary gland can respond to hormone signals, helping distinguish Kallmann syndrome from other causes of delayed puberty.
Yes, with proper fertility treatment, many people with Kallmann syndrome can have biological children. Men may receive gonadotropin injections to stimulate sperm production. Women may need gonadotropins to stimulate ovulation. Treatment can take several months to achieve fertility, and success rates vary.
Kallmann syndrome is about four times more common in males than females. This is partly because one common form is X-linked, affecting males more severely. However, females can also be affected, and their symptoms may be milder or overlooked.
Without treatment, secondary sexual characteristics will not develop, and fertility will not be possible. Long-term health risks include weak bones or osteoporosis due to low sex hormone levels. Psychological impacts from delayed development and differences from peers can also occur. Early treatment prevents most of these complications.
Unfortunately, hormone replacement therapy does not restore the sense of smell. The smell impairment is due to structural differences in the brain that develop before birth. However, treating the hormone deficiency allows for normal sexual development and prevents other health issues.
Regular monitoring is needed throughout life to adjust hormone doses and check for complications. Blood tests to measure hormone levels are typically done every few months initially, then annually once stable. Bone density scans may be recommended every few years to ensure bone health.
It can be, but not always. Some forms are inherited in X-linked, autosomal dominant, or autosomal recessive patterns. However, about 30% of cases occur spontaneously with no family history due to new genetic mutations. Genetic counseling can help families understand their specific situation and risks.